Partner Fund Management »

Adaptimmune Therapeutics shares owned by Partner Fund Management

Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Partner Fund Management from 13F filings

Historical chart of Partner Fund Management investment in Adaptimmune Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Adaptimmune Therapeutics held by Partner Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adaptimmune Therapeutics by Partner Fund Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $8.3M 10M 0.79
2023-09-30 $8.1M 10M 0.78
2023-06-30 $7.7M 8.4M 0.93
2023-03-31 $6.5M 6.0M 1.09
2022-12-31 $7.1M 4.8M 1.46
2022-09-30 $10M 9.3M 1.08
2022-06-30 $16M 9.1M 1.70
2022-03-31 $4.9M 2.4M 2.06
2021-12-31 $12M 3.2M 3.75
2021-09-30 $23M 4.4M 5.17
2021-06-30 $16M 3.6M 4.26
2021-03-31 $13M 2.5M 5.31
2020-12-31 $15M 2.7M 5.39
2020-09-30 $6.8M 849k 7.98
2015-09-30 $12M 1.0M 11.97
2015-06-30 $18M 966k 18.33